PAM
GYRE icon

Panagora Asset Management’s Gyre Therapeutics GYRE Stock Holding History

Panagora Asset Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-578
Closed -$22K – 2848
2021
Q1 		$22K Buy
578
+438
+313% +$20K ﹤0.01% 2299
2020
Q4 		$7K Sell
140
-1,601
-92% -$69.3K ﹤0.01% 2375
2020
Q3 		$56K Buy
1,741
+43
+3% +$1.68K ﹤0.01% 1988
2020
Q2 		$75K Buy
+1,698
New +$79.7K ﹤0.01% 1886
2019
Q2 		– Sell
-8
Closed – – 2639
2019
Q1 		$0 Sell
8
-3
-27% -$193 ﹤0.01% 2530
2018
Q4 		$1K Buy
11
+3
+38% +$221 ﹤0.01% 2422
2018
Q3 		$1K Sell
8
-2,485
-100% -$197K ﹤0.01% 2386
2018
Q2 		$218K Buy
2,493
+2,485
+31,063% +$436K ﹤0.01% 1629
2018
Q1 		$2K Hold
8
– – ﹤0.01% 2309
2017
Q4 		$1K Hold
8
– – ﹤0.01% 2282
2017
Q3 		$0 Hold
8
– – ﹤0.01% 2394
2017
Q2 		$0 Hold
8
– – ﹤0.01% 2626
2017
Q1 		$1K Hold
8
– – ﹤0.01% 2348
2016
Q4 		$1K Hold
8
– – ﹤0.01% 2346
2016
Q3 		$1K Hold
8
– – ﹤0.01% 2401
2016
Q2 		$1K Hold
8
– – ﹤0.01% 2291
2016
Q1 		$2K Hold
8
– – ﹤0.01% 2266
2015
Q4 		$3K Hold
8
– – ﹤0.01% 2267
2015
Q3 		$4K Sell
8
-18
-69% -$27.4K ﹤0.01% 2269
2015
Q2 		$56K Hold
26
– – ﹤0.01% 2115
2015
Q1 		$60K Sell
26
-8
-24% -$16.5K ﹤0.01% 2054
2014
Q4 		$70K Hold
34
– – ﹤0.01% 1947
2014
Q3 		$67K Sell
34
-16
-32% -$39.6K ﹤0.01% 1954
2014
Q2 		$177K Hold
50
– – ﹤0.01% 1753
2014
Q1 		$186K Sell
50
-2
-4% -$7.4K ﹤0.01% 1769
2013
Q4 		$169K Hold
52
– – ﹤0.01% 1721
2013
Q3 		$216K Buy
52
+14
+37% +$56.3K ﹤0.01% 1643
2013
Q2 		$129K Buy
+38
New +$145K ﹤0.01% 1793

Other funds holding GYRE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Panagora Asset Management's GYRE Position: Q2 2021 in Review

Panagora Asset Management sold out of Gyre Therapeutics (GYRE) in Q2 2021, closing a stake of 578 shares — an estimated $22K sold.

Panagora Asset Management first reported a position in GYRE in Q2 2013 and held it in 28 quarters. The position peaked at $218K in Q2 2018. 69 funds tracked by Wall St. Rank hold GYRE as of Q2 2021.

  • Panagora Asset Management reported no remaining Gyre Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 578 Gyre Therapeutics shares in Q2 2021, an estimated $22K.
  • Panagora Asset Management first reported a position in Gyre Therapeutics in Q2 2013 and held it in 28 quarters.
  • Panagora Asset Management's Gyre Therapeutics position peaked at $218K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.